WO2002061065A3 - Phosphorylated glyoxalase i and its use - Google Patents

Phosphorylated glyoxalase i and its use Download PDF

Info

Publication number
WO2002061065A3
WO2002061065A3 PCT/EP2002/001118 EP0201118W WO02061065A3 WO 2002061065 A3 WO2002061065 A3 WO 2002061065A3 EP 0201118 W EP0201118 W EP 0201118W WO 02061065 A3 WO02061065 A3 WO 02061065A3
Authority
WO
WIPO (PCT)
Prior art keywords
glyoxalase
phosphorylated
mammalian
present
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/001118
Other languages
French (fr)
Other versions
WO2002061065A2 (en
Inventor
Katia Vancompernolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vlaams Instituut voor Biotechnologie VIB
Original Assignee
Vlaams Instituut voor Biotechnologie VIB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vlaams Instituut voor Biotechnologie VIB filed Critical Vlaams Instituut voor Biotechnologie VIB
Priority to AU2002249173A priority Critical patent/AU2002249173A1/en
Priority to EP02718086A priority patent/EP1356029B1/en
Priority to CA002436522A priority patent/CA2436522A1/en
Priority to DE60225530T priority patent/DE60225530D1/en
Publication of WO2002061065A2 publication Critical patent/WO2002061065A2/en
Publication of WO2002061065A3 publication Critical patent/WO2002061065A3/en
Priority to US10/630,451 priority patent/US7198931B2/en
Anticipated expiration legal-status Critical
Priority to US11/598,864 priority patent/US20070059772A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a phosphorylated form of mammalian glyoxalase I. The present invention relates further to the use of phosphorylated mammalian glyoxalase I to modulate MG-modification of proteins (AGE formation) and consequent cell death, especially upon stress such as oxidative stress, or upon TNF treatment.
PCT/EP2002/001118 2001-01-31 2002-01-30 Phosphorylated glyoxalase i and its use Ceased WO2002061065A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU2002249173A AU2002249173A1 (en) 2001-01-31 2002-01-30 Phosphorylated glyoxalase i and its use
EP02718086A EP1356029B1 (en) 2001-01-31 2002-01-30 Phosphorylated glyoxalase i and its use
CA002436522A CA2436522A1 (en) 2001-01-31 2002-01-30 Phosphorylated glyoxalase i and its use
DE60225530T DE60225530D1 (en) 2001-01-31 2002-01-30 PHOSPHORYLATED GLYOXALASE I AND ITS USE
US10/630,451 US7198931B2 (en) 2001-01-31 2003-07-30 Phosphorylated glyoxalase I and its use
US11/598,864 US20070059772A1 (en) 2001-01-31 2006-11-14 Phosphorylated glyoxalase I and its use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200353 2001-01-31
EP01200353.9 2001-01-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/630,451 Continuation US7198931B2 (en) 2001-01-31 2003-07-30 Phosphorylated glyoxalase I and its use

Publications (2)

Publication Number Publication Date
WO2002061065A2 WO2002061065A2 (en) 2002-08-08
WO2002061065A3 true WO2002061065A3 (en) 2003-02-20

Family

ID=8179836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/001118 Ceased WO2002061065A2 (en) 2001-01-31 2002-01-30 Phosphorylated glyoxalase i and its use

Country Status (7)

Country Link
US (2) US7198931B2 (en)
EP (1) EP1356029B1 (en)
AT (1) ATE389014T1 (en)
AU (1) AU2002249173A1 (en)
CA (1) CA2436522A1 (en)
DE (1) DE60225530D1 (en)
WO (1) WO2002061065A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061065A2 (en) 2001-01-31 2002-08-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Phosphorylated glyoxalase i and its use
JP5288365B2 (en) * 2007-07-17 2013-09-11 学校法人東海大学 Examination and treatment of schizophrenia
WO2014123749A1 (en) * 2013-01-30 2014-08-14 Board Of Regents Of The University Of Nebraska Compositions and methods for treating complications associated with diabetes
CN112391416B (en) * 2019-08-14 2022-09-16 中国科学院分子植物科学卓越创新中心 Function and application of glyoxalase SPG

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0568571A (en) * 1991-08-13 1993-03-23 Sagami Chem Res Center Dna capable of coding human-derived glyoxalase i

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002061065A2 (en) 2001-01-31 2002-08-08 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Phosphorylated glyoxalase i and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0568571A (en) * 1991-08-13 1993-03-23 Sagami Chem Res Center Dna capable of coding human-derived glyoxalase i

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
GUY G R ET AL: "INTERLEUKIN 1 AND TUMOR NECROSIS FACTOR ACTIVATE COMMON MULTIPLE PROTEIN KINASES IN HUMAN FIBROBLASTS", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 22, 1991, pages 14343 - 14352, XP000999253, ISSN: 0021-9258 *
INOUE Y ET AL: "SEXUAL RESPONSE OF SACCHAROMYCES-CEREVISIAE PHOSPHORYLATION OF YEAST GLYOXALASE I BY A CELL EXTRACT OF MATING FACTOR-TREATED CELLS", JOURNAL OF BIOCHEMISTRY (TOKYO), vol. 108, no. 1, 1990, pages 4 - 6, XP001005285, ISSN: 0021-924X *
KIM NAM-SOON ET AL: "Human glyoxalase I: cDNA cloning, expression, and sequence similarity to glyoxalase I from Pseudomonas putida.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 15, 1993, pages 11217 - 11221, XP000999259, ISSN: 0021-9258 *
PATENT ABSTRACTS OF JAPAN vol. 017, no. 388 (C - 1086) 21 July 1993 (1993-07-21) *
RANGANATHAN SULABHA ET AL: "Cloning and characterization of human colon glyoxalase-I.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 268, no. 8, 1993, pages 5661 - 5667, XP000999251, ISSN: 0021-9258 *
SAKAMOTO HIROSHI ET AL: "Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis.", BLOOD, vol. 95, no. 10, 15 May 2000 (2000-05-15), pages 3214 - 3218, XP002170378, ISSN: 0006-4971 *
THORNALLEY PAUL J: "Advances in glyoxalase research: Glyoxalase expression in malignancy, anti-proliferative effects of methylglyoxal, glyoxalase I inhibitor diesters and S-D-lactoylglutathione, and methylglyoxal-modified protein binding and endocytosis by the advanced glycation endproduct receptor.", CRITICAL REVIEWS IN ONCOLOGY-HEMATOLOGY, vol. 20, no. 1-2, 1995, pages 99 - 128, XP001000228, ISSN: 1040-8428 *
VAN HERREWEGHE FRANKY ET AL: "Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGE.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 99, no. 2, 22 January 2002 (2002-01-22), http://www.pnas.org January 22, 2002, pages 949 - 954, XP002222256, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
US7198931B2 (en) 2007-04-03
CA2436522A1 (en) 2002-08-08
US20040067567A1 (en) 2004-04-08
ATE389014T1 (en) 2008-03-15
EP1356029A2 (en) 2003-10-29
DE60225530D1 (en) 2008-04-24
WO2002061065A2 (en) 2002-08-08
AU2002249173A1 (en) 2002-08-12
US20070059772A1 (en) 2007-03-15
EP1356029B1 (en) 2008-03-12

Similar Documents

Publication Publication Date Title
WO2001064920A3 (en) Hybrid expression of neisserial proteins
WO2002036743A3 (en) Antisense modulation of calreticulin expression
WO2002087419A3 (en) Biological pacemaker
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
WO2003010284A3 (en) Antisense modulation of c-reactive protein expression
EP1988099A3 (en) Bacillus thuringiensis insecticidal proteins
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
AU1044500A (en) Imidazonaphthyridines
WO2003054154A3 (en) Antisense modulation of mucin 1, transmembrane expression
AU7520898A (en) Tetrahydropyrido compounds
AU7061700A (en) Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators
AU2001258373A1 (en) Method for identifying helicobacter antigens
WO2002062954A3 (en) Antisense modulation of casein kinase 2-beta expression
WO2002062818A3 (en) Antisense modulation of casein kinase 2-alpha expression
WO2002061065A3 (en) Phosphorylated glyoxalase i and its use
WO2003070878A3 (en) Antisense modulation of hematopoietic cell protein tyrosine kinase expression
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO2003050247A3 (en) Antisense modulation of mhc class ii transactivator expression
EP1436279B8 (en) Chemical compounds
WO2002038803A3 (en) Novel marker for the diagnosis and therapy of tumours
MX9701764A (en) Imidic acid derivatives and their use as pesticides.
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
WO2003028666A3 (en) Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
AU6722498A (en) Disubstituted biphenyloxazolines
WO2001066740A3 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2002718086

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2436522

Country of ref document: CA

Ref document number: 10630451

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2002718086

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWG Wipo information: grant in national office

Ref document number: 2002718086

Country of ref document: EP